Abstract
Background
We report a case of recurrent cytomegalovirus (CMV) retinitis in an HIV-negative patient with CD4+ T lymphocytopenia.
Methods
Case report.
Results
A 41-year-old HIV-negative woman with a history of systemic lupus erythematosus, idiopathic thrombocytopenic purpura requiring splenectomy, and diabetes presented with primary CMV infection, high-grade viremia, CMV pneumonia followed by CMV retinitis (CMVR) and a CD4+ T lymphocyte (CD4) count of 12 cells/mm3 after therapy with rituximab, prednisone, and methotrexate. Persistent CMV viremia led to genotypic analysis of the circulating virus, which revealed UL97 and UL54 mutations known to be associated with resistance to ganciclovir (GCV) and cidofovir. CMV clearance from the bloodstream followed systemic antiviral therapy and recovery of CD4 cell count. However, CMVR recurred multiple times despite GCV implants, systemic valganciclovir, intravitreal GCV injections, and persistent CD4 counts greater than 100 cells/mm3. Recurrent episodes of CMVR responded to multiple high dose intravitreal GCV injections (5000–6000 micrograms) and recovery of CD4 cell counts to greater than 200 cells/mm3.
Conclusion
This case demonstrates that recurrent CMVR occurs in HIV-negative patients at CD4 cell counts thought to be protective in HIV patients, and suggests that an ineffective local immune response to retinal infection combined with CMV drug resistance may have been important factors leading to recurrent disease in this patient. Treatment producing high local concentrations of GCV may be effective therapy for CMV retinitis due to GCV-resistant virus.
This is a preview of subscription content, log in via an institution to check access.
References
Pertel P, Hirschtick R, Phair J, Chmiel J, Poggensee L, Murphy R (1992) Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr 5(11):1069–1074
Giorgi D, Balacco Gabrieli C (1999) Optic neuropathy in systemic lupus erythematosus and antiphospholipid syndrome (APS): Clinical features, pathogenesis, review of the literature and proposed ophthalmological criteria for APS diagnosis. Clin Rheumatol 18(2):124–131, Review
Smith WG, Briggs JD, Junor BJ, Jay JL (1985) Ischaemic optic neuropathy and retinopathy associated with acute pancreatitis. Scott Med J 30(1):46–47
Gilbert C, Boivin G (2005) Human cytomegalovirus resistance to antiviral drugs. Antimicrob Agents Chemother 49(3):873–883
Vrabec TR, Baldassano VF, Whitcup SM (1998) Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts. Ophthalmology 105(7):1259–1264
Curi A, Muralha A, Muralha L et al (2001) Suspension of anticytomegalovirus maintenance therapy following immune recovery due to highly active antiretroviral therapy. Br J Ophthalmol 85(4):471–473
Arevalo JF, Garcia RA, Mendoza AJ (2005) High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela. Eur J Ophthalmol 15(5):610–618
Acknowledgments
Supported by an unrestricted grant from Research to Prevent Blindness, New York, NY (DAG).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hoang, Q.V., Simon, D.M., Kumar, G.N. et al. Recurrent CMV retinitis in a non-HIV patient with drug-resistant CMV. Graefes Arch Clin Exp Ophthalmol 248, 737–740 (2010). https://doi.org/10.1007/s00417-009-1283-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-009-1283-3